A Random Change Point Model for Cognitive Decline in Alzheimer’s Disease and Mild Cognitive Impairment
Year: 2012
Type: article
Study design: Observational Study
Abstract: BACKGROUND: We present a random change point model to characterize decline in cognition among community-based elderly who developed Alzheimer's disease (AD) or amnestic mild cognitive impairment (MCI), and to examine how decline varies with age, sex, education, and APOE status. METHODS: Using longitudinal cohort data on cognitive function, we fit a piecewise linear trajectory with a random change point that allows different rates of cognitive decline before and after the change point. We estimated the change point that signals the onset of cognitive impairment, and examined the association of risk factors with the location of the change point as well as the rates of decline before and after the change point. RESULTS: Among participants who were dementia free at enrollment and developed incident AD, the change point occurred on average 5.7 years after enrollment and the rate of cognitive decline after the change point nearly quadrupled. Age, education, and APOE status play important but different roles in the timing of the onset of cognitive impairment and in the rates of decline before and after its onset. Results were similar among participants who were cognitively unimpaired at enrollment but later developed amnestic MCI or AD. CONCLUSIONS: The random change point model provides a more comprehensive understanding of the relation of risk factors with the onset of cognitive impairment and rates of decline before and after its onset.
Source: Neuroepidemiology
DOI: 10.1159/000339365
Authors: Lei Yu, Patricia Boyle, Robert S. Wilson, Eisuke Segawa, Sue Leurgans, Philip L. De Jager, David A. Bennett
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Institute on Aging
Awards: G1061674020, Epidemiologic Study of Neural Reserve and Neurobiology of Aging, G1184234779, G1282666458, G1743036345, G202214154, G2200385677, G249615658, Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences, Risk Factors, Pathology, and Clinical Expressions of AD, Rush Alzheimer's Disease Core Center, Cognitive Decline and Dementia: Life Experiences and the Brain Histone Epigenome, Epidemiologic Study of Decision Making in Preclinical Alzheimer's Disease, Characterizing the Behavior Profile of Healthy Cognitive Aging
OpenAlex ID: W2007104310
